Huperzine A, CAS# 102518-79-6, is a Plant extracts manufactured through plant extraction, available as Brownish yellow to brown powder. Huperzine A is widely used as nutrition supplements. It is widely accepted as safe food additive in many countries.
No significant side effects reported.
As Huperzine A Side Effects is widely known as safe, there is no limit on dosage of intake. However, we still recommend consumers to consult professionals before using large quantity of Huperzine A Side Effects for long period.
Special groups refer to newborns, children, pregnant and any other applicable vulnerable groups.
There is no evidence that Huperzine A Side Effects could have any negative effects on these vulnerable groups. It should be safe to use Huperzine A Side Effects in food for newborns and pregnant. However, we still recommend consumers to consult professionals before using large quantity of Huperzine A Side Effects for long period in food for newborns or pregnant.
Though Huperzine A Side Effects is not on FDA's GRAS exemption list, it's still widely accepted as safe food additive in many countries including USA with specific limit on dosage.
No health issues about Huperzine A Side Effects reported up to now.
1. Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A. [Int J Pharm. 2013 Mar 25]
Author: Patel PA, Patil SC, Kalaria DR, Kalia YN, Patravale VB.
2. Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine A. [Proc Natl Acad Sci U S A. 2013 Feb 19]
Author: Yu D, Thakor DK, Han I, Ropper AE, Haragopal H, Sidman RL, Zafonte R, Schachter SC, Teng YD.
3. Treatment with Huperzine A improves cognition in vascular dementia patients. [Cell Biochem Biophys. 2012 Jan]
Author: Xu ZQ, Liang XM, Juan-Wu, Zhang YF, Zhu CX, Jiang XJ.
4. Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine. [J Pharmacol Exp Ther. 2009 Dec]
Author: Aracava Y, Pereira EF, Akkerman M, Adler M, Albuquerque EX.